26 May 2013
Keywords: gsk, files, expand, tyverb, use, usa, eu
Article | 03 April 2009
UK drug major GlaxoSmithKline has submitted simultaneous US and European regulatory applications to expand the use of Tyverb/Tykerb
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 April 2009
24 May 2013
© 2013 thepharmaletter.com